• Frequently Asked Questions About a GLP-1 RA Treatment Option for T2D
    Oct 27 2023

    What do you need to know about a once daily GLP-1 RA therapy for adults with T2D? Join experts in T2D Aaron King, MD, Helen Baron, MD, and Stephen Brunton, MD, FAAP, FRACGP, CDCES, as they discuss frequently asked questions regarding the use of a once daily treatment for adults with T2D with the goal of helping to provide answers. Key topics include dosing and administration, handling and storage, as well as efficacy and safety.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    Aaron King, MD
    Physician
    Baptist Health System Physicians 
    San Antonio, TX

    Helen L. Baron, MD
    Medical Director, Diabetes Services
    Eisenhower Diabetes and Endocrinology
    Montrose, CA

    Stephen Brunton, MD, FAAFP, CDCES
    Executive Director
    Primary Care Metabolic Group
    Winnsboro, SC

    Show More Show Less
    42 mins
  • Patient-Focused Care in T2D: The Pharmacist’s Role in GLP-1 RA Education
    Oct 27 2023

    What is the role of the pharmacist in patient-centered care of adults with type 2 diabetes (T2D)? Join pharmacist experts in T2D Jennifer Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, Melody Hartzler, PharmD, BCACP, BC-ADM, AE-C, and Donald Nuzum, PharmD, BCACP, BC-ADM, CDCES, as they discuss education of patients and pharmacists on the pharmacokinetics, administration, dosing schedule and handling of a GLP-1 receptor agonist (GLP-1 RA). They will also consider when to use a GLP-1 RA, where they review clinical data on efficacy and safety of a GLP-1 RA, including in a trial when used as monotherapy vs placebo, a head-to-head study vs a DPP-4 inhibitor, and a cardiovascular outcomes study.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP
    Professor of Pharmacy Practice & Clinical Pharmacist, Director of Cardiometabolic Services
    Massachusetts College of Pharmacy and Health Sciences, Boston, MA; Well Life Medical, Peabody, MA

    Melody L. Hartzler, PharmD, BCACP, BC-ADM
    Clinical Pharmacist & CEO
    PharmToTable, LLC
    Centerville, OH

    Donnie Nuzum, PharmD, BCACP, BC-ADM, CDCES
    Associate Professor of Pharmacy, Clinical Pharmacist
    Wingate University, Avance Primary Care
    Indian Trail, North CA

    Show More Show Less
    49 mins
  • Explore A Treatment Option to Improve Glycemic Control in Adults With T2D
    Oct 23 2023

    Explore a treatment option to improve glycemic control in adults with T2D and when you should consider using a GLP-1 RA. Join experts in T2D Aaron King, MD, Davida Kruger, MSN, APRN-BC, and Javier Morales, MD, as they review the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as dosing, administration, and the monotherapy data of a once daily GLP-1 RA for T2D treatment.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    Aaron King, MD
    Physician
    Baptist Health System Physician
    San Antonio, TX

    Davida F. Kruger, MSN, APRN‐BC, BC‐ADM
    Certified Nurse Practitioner
    A Henry Ford Health System,
    Division of Endocrinology, Diabetes,
    Bone and Mineral Disorders
    Detroit, MI

    Javier Morales, MD, FACP, FACE
    Associate Clinical Professor of Medicine
    Hofstra Northwell
    Huntington, NY

    Show More Show Less
    42 mins
  • What T2D Therapy Have You Considered for Your Patients After Metformin?
    Aug 22 2022

    How common is treatment inertia in the treatment of adult patients with T2D and what can be done about it? Join a multidisciplinary panel including Jim Gavin, MD, PhD; Steve Vacalis, DO; and Jodi Strong, DNP, CDE, BC-ADM, CPT as they discuss and share their insights on the issues surrounding therapeutic inertia. They will also evaluate when to use a GLP-1 RA, and a clinical trial comparing the efficacy and safety of a GLP-1 RA versus a DPP-4i.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    James R. Gavin III, MD, PhD
    Clinical Professor of Medicine, Emory University
    Chief Medical Officer, Healing Our Village, Inc.
    Atlanta, Georgia

    Jodi Strong, DNP, CDCES, BC-ADM, CPT
    Aspirus Medical Group
    Stevens Point, Wisconsin

    Steve Vacalis, DO
    Senior Lead Physician
    CaroMont Family Medicine, CaroMont Regional Medical Center 
    Gastonia, North Carolina

    Show More Show Less
    40 mins
  • How to Empower Patients with T2D Knowledge and Introduce a GLP-1 RA
    Aug 11 2022

    What do you need to know about a once-daily GLP-1 RA and what can you do to help your patients taking this T2D therapy? Join this multidisciplinary discussion with Jim Gavin, MD; Curtis Triplitt, PharmD; and Jeffrey Unger, MD, as they review the mechanism of action, dosing, efficacy, and safety of a once-daily GLP-1 RA for adult patients with T2D. 

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    James R. Gavin III, MD, PhD
    Clinical Professor of Medicine, Emory University
    Chief Medical Officer, Healing Our Village, Inc.
    Atlanta, Georgia

    Jeff Unger, MD, FAAFP, FACE
    Diplomate, American Board of Family Practice
    Assistant Clinical Professor of Family Medicine, UC Riverside School of Medicine
    Riverside, California
    Director, Unger Concierge Primary Care Medical Group
    Rancho Cucamonga, California

    Curtis L. Triplitt, PharmD, CDCES, FADCES
    Clinical Associate Professor of Medicine Division of Diabetes
    University of Texas Health at San Antonio
    Texas Diabetes Institute, part of the University Health System
    San Antonio, Texas

    Show More Show Less
    35 mins
  • Could This GLP-1 RA be Right for Your Adult Patients With T2D?
    Jun 6 2022

    Join leaders in the field of diabetes Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment?

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:  

    James R. Gavin III, MD, PhD
    Clinical Professor of Medicine, Emory University
    Chief Medical Officer, Healing Our Village, Inc.
    Atlanta, Georgia

    Robert Busch, MD
    Director of Clinical Research
    Albany Med Faculty Practice, Community Endocrine Group
    Albany, New York  

    Pablo F. Mora, MD, FACE, MSc, CDCES
    Endocrinologist, North Texas Diabetes & Endocrinology
    Clinical Professor, Division of Endocrinology at University of Texas Southwestern Medical Center
    Dallas, Texas

    Show More Show Less
    24 mins